25/03/2026
🔭 Risk management plans (RMP) are regulatory documents that identify and characterise the safety profile of medicinal products, define measures to minimise risks, and ensure that benefits outweigh risks once a medicine reaches the market. But what if structured risk thinking started in the early phases of clinical development?
Pedro Caetano and Laura Campora discuss how development risk management plans (DRMP) can help shift the risk mindset to support better benefit–risk decision-making and .
Get the full insight in 👉 https://ow.ly/efAp50YrGm8